A detailed history of Israel Englander (Millennium Management LLC) transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Millennium Management LLC holds 4,346,151 shares of TAK stock, worth $64.4 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
4,346,151
Previous 2,322,444 87.14%
Holding current value
$64.4 Million
Previous $32.3 Million 74.34%
% of portfolio
0.03%
Previous 0.01%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$12.6 - $13.67 $25.5 Million - $27.7 Million
2,023,707 Added 87.14%
4,346,151 $56.2 Million
Q1 2024

May 15, 2024

SELL
$13.89 - $15.04 $57.9 Million - $62.7 Million
-4,170,467 Reduced 64.23%
2,322,444 $32.3 Million
Q4 2023

Feb 14, 2024

BUY
$13.36 - $15.43 $45.5 Million - $52.6 Million
3,407,745 Added 110.46%
6,492,911 $92.7 Million
Q2 2023

Aug 14, 2023

SELL
$15.57 - $17.11 $11.8 Million - $12.9 Million
-754,816 Reduced 19.66%
3,085,166 $48.5 Million
Q1 2023

May 15, 2023

BUY
$15.28 - $16.48 $24.5 Million - $26.4 Million
1,601,601 Added 71.55%
3,839,982 $63.3 Million
Q4 2022

Feb 14, 2023

BUY
$12.42 - $15.62 $15.4 Million - $19.4 Million
1,239,382 Added 124.06%
2,238,381 $34.9 Million
Q3 2022

Nov 14, 2022

SELL
$12.8 - $28.65 $3.13 Million - $7 Million
-244,423 Reduced 19.66%
998,999 $13 Million
Q2 2022

Aug 15, 2022

BUY
$13.12 - $15.03 $7.44 Million - $8.53 Million
567,291 Added 83.9%
1,243,422 $17.5 Million
Q1 2022

May 16, 2022

BUY
$13.54 - $15.35 $8.55 Million - $9.69 Million
631,280 Added 1407.5%
676,131 $9.68 Million
Q4 2021

Feb 14, 2022

BUY
$13.17 - $16.4 $384,326 - $478,584
29,182 Added 186.24%
44,851 $611,000
Q3 2021

Nov 15, 2021

SELL
$16.3 - $17.26 $3.75 Million - $3.97 Million
-230,243 Reduced 93.63%
15,669 $257,000
Q2 2021

Aug 16, 2021

BUY
$16.55 - $18.64 $1.8 Million - $2.02 Million
108,463 Added 78.91%
245,912 $4.14 Million
Q1 2021

May 17, 2021

BUY
$16.71 - $19.9 $2.3 Million - $2.74 Million
137,449 New
137,449 $2.51 Million
Q4 2020

Feb 16, 2021

SELL
$15.39 - $18.97 $7.93 Million - $9.78 Million
-515,404 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$17.1 - $19.19 $6.13 Million - $6.88 Million
-358,519 Reduced 41.02%
515,404 $9.2 Million
Q2 2020

Aug 14, 2020

SELL
$14.59 - $19.5 $529,441 - $707,616
-36,288 Reduced 3.99%
873,923 $15.7 Million
Q1 2020

May 14, 2020

BUY
$13.02 - $20.31 $7.46 Million - $11.6 Million
572,940 Added 169.88%
910,211 $13.8 Million
Q4 2019

Feb 14, 2020

BUY
$16.88 - $20.83 $5.69 Million - $7.03 Million
337,271 New
337,271 $6.65 Million
Q3 2019

Nov 14, 2019

SELL
$16.15 - $17.99 $3.03 Million - $3.37 Million
-187,487 Closed
0 $0
Q2 2019

Aug 15, 2019

BUY
$16.58 - $20.49 $2.91 Million - $3.59 Million
175,256 Added 1432.88%
187,487 $3.32 Million
Q2 2019

Aug 14, 2019

SELL
$16.58 - $20.49 $31.9 Million - $39.5 Million
-1,926,978 Reduced 99.37%
12,231 $1.28 Million
Q1 2019

May 14, 2019

BUY
$16.7 - $21.52 $32.2 Million - $41.5 Million
1,926,409 Added 15050.07%
1,939,209 $39.5 Million
Q4 2018

Feb 14, 2019

BUY
$15.64 - $21.1 $200,192 - $270,080
12,800 New
12,800 $215,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $46B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.